Contego Medical Inc. Overview
Pro stress-test →Contego Medical develops devices designed to improve patient outcomes and procedural efficiency during revascularization treatment for carotid and peripheral vascular disease. Founded in 2005 and based in Raleigh, North Carolina, the company specializes in integrated embolic protection systems that simplify complex vascular procedures.
Strategic Profile
Pro stress-test →In October 2024, the company achieved FDA premarket approval (PMA) for the Neuroguard IEP® System, a unique 3-in-1 carotid stenting system. Contego Medical has raised $66M in funding and operates as a Series D company, positioning itself as a specialist in vascular device innovation with a portfolio of FDA-cleared and CE-marked products.
Competitive Landscape
Pro stress-test →Top competitors include SMT, Aortyx, and Thrombolex. Contego competes in the vascular embolic protection and carotid stenting segment against both specialized device makers and larger medtech platforms. The company's differentiation rests on integrated multi-functional device design and recent regulatory clearances, though it faces entrenched competition from larger players with broader distribution networks.
Industry Context
Contego Medical Inc. operates in Vascular embolic protection and carotid stenting devices.
Key facts
Founded: 2005 · Headquarters: Raleigh, North Carolina · Employees: 50 · Revenue: $5M